143 related articles for article (PubMed ID: 32045239)
1. Structure-Activity Relationship Studies on Diversified Salicylamide Derivatives as Potent Inhibitors of Human Adenovirus Infection.
Xu J; Berastegui-Cabrera J; Chen H; Pachón J; Zhou J; Sánchez-Céspedes J
J Med Chem; 2020 Mar; 63(6):3142-3160. PubMed ID: 32045239
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a Small Molecule Inhibitor of Human Adenovirus Capable of Preventing Escape from the Endosome.
Xu J; Berastegui-Cabrera J; Carretero-Ledesma M; Chen H; Xue Y; Wold EA; Pachón J; Zhou J; Sánchez-Céspedes J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562748
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel Substituted
Xu J; Berastegui-Cabrera J; Ye N; Carretero-Ledesma M; Pachón-Díaz J; Chen H; Pachón-Ibáñez ME; Sánchez-Céspedes J; Zhou J
J Med Chem; 2020 Nov; 63(21):12830-12852. PubMed ID: 33112138
[TBL] [Abstract][Full Text] [Related]
4. Optimization of piperazine-derived ureas privileged structures for effective antiadenovirus agents.
Mazzotta S; Marrugal-Lorenzo JA; Vega-Holm M; Serna-Gallego A; Álvarez-Vidal J; Berastegui-Cabrera J; Pérez Del Palacio J; Díaz C; Aiello F; Pachón J; Iglesias-Guerra F; Vega-Pérez JM; Sánchez-Céspedes J
Eur J Med Chem; 2020 Jan; 185():111840. PubMed ID: 31711794
[TBL] [Abstract][Full Text] [Related]
5. New 4-Acyl-1-phenylaminocarbonyl-2-phenylpiperazine Derivatives as Potential Inhibitors of Adenovirus Infection. Synthesis, Biological Evaluation, and Structure-activity Relationships.
Sánchez-Céspedes J; Martínez-Aguado P; Vega-Holm M; Serna-Gallego A; Candela JI; Marrugal-Lorenzo JA; Pachón J; Iglesias-Guerra F; Vega-Pérez JM
J Med Chem; 2016 Jun; 59(11):5432-48. PubMed ID: 27195951
[TBL] [Abstract][Full Text] [Related]
6. Antiviral Effects of Novel 2-Benzoxyl-Phenylpyridine Derivatives.
Wei Y; Wang H; Xi C; Li N; Li D; Yao C; Sun G; Ge H; Hu K; Zhang Q
Molecules; 2020 Mar; 25(6):. PubMed ID: 32204528
[TBL] [Abstract][Full Text] [Related]
7. Novel quinolizidine salicylamide influenza fusion inhibitors.
Yu KL; Ruediger E; Luo G; Cianci C; Danetz S; Tiley L; Trehan AK; Monkovic I; Pearce B; Martel A; Krystal M; Meanwell NA
Bioorg Med Chem Lett; 1999 Aug; 9(15):2177-80. PubMed ID: 10465540
[TBL] [Abstract][Full Text] [Related]
8. Broad-spectrum antiviral activity of the deubiquitinase inhibitor HBX against human adenoviruses.
Kosulin K; Lam E; Heim A; Dobner T; Rodríguez E
Antivir Ther; 2018; 23(6):475-483. PubMed ID: 29557344
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid receptor β, a potential therapeutic target in the inhibition of adenovirus replication.
Wang X; Zhang Q; Zhou Z; Liu M; Chen Y; Li J; Xu L; Guo J; Li Q; Yang J; Wang S
Antiviral Res; 2018 Apr; 152():84-93. PubMed ID: 29421320
[TBL] [Abstract][Full Text] [Related]
10. HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model.
Toth K; Spencer JF; Ying B; Tollefson AE; Wold WSM
Viruses; 2017 Jun; 9(6):. PubMed ID: 28608847
[TBL] [Abstract][Full Text] [Related]
11. Effect of brincidofovir on adenovirus and A549 cells transcriptome profiles.
Salmona M; Feghoul L; Mercier-Delarue S; Diaz E; Splitberger M; Armero A; Dalle JH; Dutrieux J; LeGoff J
Antiviral Res; 2020 Oct; 182():104872. PubMed ID: 32768412
[TBL] [Abstract][Full Text] [Related]
12. Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Suppresses Human Adenovirus Gene Expression and Replication.
Saha B; Parks RJ
J Virol; 2019 Jun; 93(12):. PubMed ID: 30944181
[TBL] [Abstract][Full Text] [Related]
13. Comparative Study on the Antivirus Activity of Shuang-Huang-Lian Injectable Powder and Its Bioactive Compound Mixture against Human Adenovirus III In Vitro.
Ma Q; Liang D; Song S; Yu Q; Shi C; Xing X; Luo JB
Viruses; 2017 Apr; 9(4):. PubMed ID: 28417913
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and in vitro biological evaluation of a novel class of anti-adenovirus agents based on 3-amino-1,2-propanediol.
Mazzotta S; Berastegui-Cabrera J; Vega-Holm M; García-Lozano MDR; Carretero-Ledesma M; Aiello F; Vega-Pérez JM; Pachón J; Iglesias-Guerra F; Sánchez-Céspedes J
Bioorg Chem; 2021 Sep; 114():105095. PubMed ID: 34175724
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of salicylamide derivatives for combating viral infections.
Xu J; Xue Y; Bolinger AA; Li J; Zhou M; Chen H; Li H; Zhou J
Med Res Rev; 2023 Jul; 43(4):897-931. PubMed ID: 36905090
[TBL] [Abstract][Full Text] [Related]
16. Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies.
Dodge MJ; MacNeil KM; Tessier TM; Weinberg JB; Mymryk JS
Antiviral Res; 2021 Apr; 188():105034. PubMed ID: 33577808
[TBL] [Abstract][Full Text] [Related]
17. Identification of human adenovirus replication inhibitors from a library of small molecules targeting cellular epigenetic regulators.
Saha B; Parks RJ
Virology; 2021 Mar; 555():102-110. PubMed ID: 33032802
[TBL] [Abstract][Full Text] [Related]
18. Indirubin-3'-monoxime exhibits potent antiviral and anti-inflammatory effects against human adenoviruses in vitro and in vivo.
Wang J; Yang C; Liang Z; Sun J; Zhang M; Qiu S; Du X; He X; Pang X; Ma X; Xie M; Han X; Fan R; Zhou E; Yu H; She D; Song H; Wang J
Biomed Pharmacother; 2024 May; 174():116558. PubMed ID: 38603887
[TBL] [Abstract][Full Text] [Related]
19. Pentavalent Sialic Acid Conjugates Block Coxsackievirus A24 Variant and Human Adenovirus Type 37-Viruses That Cause Highly Contagious Eye Infections.
Johansson E; Caraballo R; Mistry N; Zocher G; Qian W; Andersson CD; Hurdiss DL; Chandra N; Thompson R; Frängsmyr L; Stehle T; Arnberg N; Elofsson M
ACS Chem Biol; 2020 Oct; 15(10):2683-2691. PubMed ID: 32845119
[TBL] [Abstract][Full Text] [Related]
20. LINCS dataset-based repositioning of rosiglitazone as a potential anti-human adenovirus drug.
Wang X; He S; Zhou Z; Bo X; Qi D; Fu X; Wang Z; Yang J; Wang S
Antiviral Res; 2020 Jul; 179():104789. PubMed ID: 32353383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
